Disruption of lipid rafts or blocking ERK/Rac1 signaling abolishes these effects, and in vivo tumor-bearing mouse models show elevated serum s-uPAR correlating with angiogenesis [123]. The gene discussed is MAPK1; the disease is neoplasm.